Literature DB >> 7949138

Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.

K Leroy-Viard1, M A Vinit, N Lecointe, D Mathieu-Mahul, P H Roméo.   

Abstract

The tal-1 gene, frequently activated in human T-cell acute lymphoblastic leukemia (T-ALL), is expressed in the erythroid, megakaryocytic, and mast cell lineages during normal hematopoiesis. To gain further insight into the molecular mechanisms that control tal-1 expression, we investigated tal-1 chromatin structure in erythroid/megakaryocytic cell lines and in T-cell lines either with or without tal-1 rearrangements. Tal-1 transcription was shown to be monoallelic in Jurkat, a T-cell line that expresses tal-1 in the absence of apparent genomic alteration of the locus. Methylation studies indicated that the tal-15' GC-rich region behaves like a CpG island, hypomethylated in normal cells, and methylated de novo on transcriptionally inactive alleles in established cell lines. Five major DNase-I hypersensitive sites (HS) were mapped in the tal-1 locus. HS I, IV, and V were exclusively observed in the erythroid/megakaryocytic cell lines that express tal-1 from the promoters 1a and 1b. HS II was weak in hematopoietic cell lines, absent in Hela, and greatly enhanced in Jurkat, suggesting that this region might be implicated in the cis-activation of tal-1 promoter 1b in this cell line. HS III was weak in HEL and Jurkat, and greatly enhanced in DU528, a T-cell line that bears a t (1;14) and initiates tal-1 transcription within exon 4. These results suggest that distinct regulatory elements are associated with the use of the different tal-1 promoters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949138

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL.

Authors:  Adrian Rivera-Reyes; Katharina E Hayer; Craig H Bassing
Journal:  Trends Mol Med       Date:  2016-10-27       Impact factor: 11.951

2.  A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.

Authors:  R A Shivdasani; Y Fujiwara; M A McDevitt; S H Orkin
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

3.  Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.

Authors:  Pawandeep Dhami; Alexander W Bruce; Johanna H Jim; Shane C Dillon; Amanda Hall; Jonathan L Cooper; Nicolas Bonhoure; Kelly Chiang; Peter D Ellis; Cordelia Langford; Robert M Andrews; David Vetrie
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 4.  The role of noncoding mutations in blood cancers.

Authors:  Sunniyat Rahman; Marc R Mansour
Journal:  Dis Model Mech       Date:  2019-11-26       Impact factor: 5.758

5.  The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis.

Authors:  Claudia Scholl; Dimple Bansal; Konstanze Döhner; Karina Eiwen; Brian J P Huntly; Benjamin H Lee; Frank G Rücker; Richard F Schlenk; Lars Bullinger; Hartmut Döhner; D Gary Gilliland; Stefan Fröhling
Journal:  J Clin Invest       Date:  2007-03-08       Impact factor: 14.808

6.  Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

Authors:  K Leroy-Viard; M A Vinit; N Lecointe; H Jouault; U Hibner; P H Roméo; D Mathieu-Mahul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.